FDA Should Form Alliance With CMS To Convey Drug Risk Information To Elderly, NCPIE Says
This article was originally published in The Pink Sheet Daily
Social security checks could be another way to reach elderly patients with drug risk information, panelists suggested at FDA's public hearing on drug safety communication.
You may also be interested in...
Dr. Reddy's, GSK, Ranbaxy and UCB among manufacturers that could see prices reduced under government order that reflects issues raised in Gleevec patent dispute.
Indian regulators threaten compulsory licensing of the oncologic, but Novartis says it has no plans to end its bid for patent protection.
Patent case for new form of imatinib will now be reviewed by newly formed Intellectual Property Appellate Board.